The immune microenvironment of human tumors: general significance and clinical impact
about
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentInterest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer VaccineMast cells as a potential prognostic marker in prostate cancerThe promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinomaPrognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma.Prognostic potential of an immune score based on the density of CD8+ T cells, CD20+ B cells, and CD33+/p-STAT1+ double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients.Gamma interferon-induced guanylate binding protein 1 is a novel actin cytoskeleton remodeling factor.Role of LAP+CD4+ T cells in the tumor microenvironment of colorectal cancer.Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.HLA ligandome tumor antigen discovery for personalized vaccine approach.Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity.Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence.Immunotherapy for pancreatic cancer: present and future.Immunotherapy for gastric cancers: emerging role and future perspectives.Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.The status of donor cancer tissues affects the fate of patient-derived colorectal cancer xenografts in NOG mice.Functional impairment of infiltrating T cells in human colorectal cancer.Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.Expression of Cytokines Interleukin-2, Interleukin-4, Interleukin-10 and Transforming Growth Factor β in Gastric Adenocarcinoma Biopsies Obtained from Mexican PatientsA Believer's Overview of Cancer Immunosurveillance and Immunotherapy.Excellent response to chemotherapy post immunotherapy.Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.Enhanced gastric cancer growth potential of mesenchymal stem cells derived from gastric cancer tissues educated by CD4(+) T cells.Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer.Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients.The treatment of canine mast cell tumours with electrochemotherapy with or without surgical excision.Quantitative and Qualitative Analysis of Tumor-Associated CD4⁺ T Cells.Topography of cancer-associated immune cells in human solid tumors
P2860
Q26738359-7A1DF143-5F9E-431D-8AE9-55856ADA1FABQ26782583-E5A34C5A-8385-4C6A-B7CB-BAB7C3C0A1EEQ26827773-40631E7A-E14E-4C05-B105-A5237A92FAFCQ28069924-D79EDA17-A16E-4944-BD14-34744958F0B5Q34041661-7445FC0E-BF27-448B-B13C-6878708DBA26Q34105741-110A4BFF-522C-4F48-B945-3DFB0758157BQ34610964-9CFAC97B-7879-4A7E-9550-7C9C956B4D5CQ37402113-F0ABE2D2-4562-4386-97D2-EB6685F339E2Q37546046-1C757FAE-CDA7-4BD2-AB57-17F6FA8D2C58Q37624495-D20A7E4C-A9A8-45D6-966A-A4E4483DD879Q37697529-F69D4038-D348-49D9-91EB-C14806A85D13Q38148779-D9A5605B-710C-4178-AA6E-5298FFCB5E2BQ38172131-466E28C4-8303-44C5-8A31-0654539FCDCDQ38197678-B1F57451-B614-4CD5-841C-84F4231BCD48Q38673158-CF3FC704-F421-40C0-82F9-A51982A06160Q38738652-E6F1D238-3AF8-48E6-B89E-A0842204F955Q38919780-86A41FEB-751E-4AD1-AE02-21447C04E2FAQ38961444-2C867DFC-80BA-41FD-82C1-2BB7EE656EDEQ39032845-3DF5B662-803A-42BF-9948-5E4124311872Q39079676-A8D53DE1-2751-40E2-9F5E-92CE592F523BQ40146273-77B4BC18-C94D-4FC8-B262-18294622CFDBQ41813201-58A5005C-0867-4E9A-B085-15A8743C01CEQ47195265-46A83F4F-EF0A-4389-A6C2-1C6B393A92F1Q47259728-23D0F080-79EF-4B98-B978-7C42E465C453Q47727375-A66D162D-F72A-4036-BAF2-2D1613C4A3CEQ48150040-DD0D4DD1-1677-4C05-A869-E5D22546CF03Q50550722-0EC3D888-EF50-43EE-ABEF-9495CE6BD7A2Q52758918-5AD6539D-FA00-44E1-849D-499B51ACA023Q53142776-53BA0F88-0017-415E-B6D6-F6ACFB8607BAQ54518729-F8113FD6-0B8C-42AA-9BF7-5258AE1E6908Q58423771-8B6827F7-7CA6-4E59-8540-FC94B5CE493C
P2860
The immune microenvironment of human tumors: general significance and clinical impact
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The immune microenvironment of human tumors: general significance and clinical impact
@en
The immune microenvironment of human tumors: general significance and clinical impact.
@nl
type
label
The immune microenvironment of human tumors: general significance and clinical impact
@en
The immune microenvironment of human tumors: general significance and clinical impact.
@nl
prefLabel
The immune microenvironment of human tumors: general significance and clinical impact
@en
The immune microenvironment of human tumors: general significance and clinical impact.
@nl
P2860
P50
P1433
P1476
The immune microenvironment of human tumors: general significance and clinical impact
@en
P2093
Franck Pagès
Wolf-Herman Fridman
P2860
P2888
P304
P356
10.1007/S12307-012-0124-9
P50
P577
2012-10-30T00:00:00Z